SOPH Q4 2022 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q4 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$13M+22.4% YoY

Gross Profit

$10M72.0% margin

Operating Income

-$15M-112.7% margin

Net Income

-$14M-104.4% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+14.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$244M

Total Liabilities

$44M

Stockholders' Equity

$200M

Cash & Equivalents

$161M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+22.4%
Gross Profit	$10M	$7M	+41.0%
Operating Income	-$15M	-$21M	+28.2%
Net Income	-$14M	-$21M	+34.6%